Antifolates
Links shared publicly online about this topic
Antifolates show promise against NSCLC subtype
eurekalert.org — “Patients with non-small cell lung cancer who have mutations in the KRAS gene should respond well to the antifolate class of drugs, according to results of a recent study conducted by Quintiles comparing human lung cancer cell lines and patients.” View full resource at eurekalert.org
Most Recently Shared on November 14, 2011 at 8:05 pm By:
Antifolates show promise against NSCLC subtype: (American Association for Cancer Research) Patients with non-sma... http://t.co/uVA7df4F
Antifolates show promise against lung cancer subtype - News
virtualmedicalcentre.com — “Patients with non-small cell lung cancer who have mutations in the KRAS gene should respond well to the antifolate class of drugs, according to results of a recent study.” View full resource at virtualmedicalcentre.com
Most Recently Shared on November 25, 2011 at 1:14 pm By:
VirtualMedicalCentre Health Site
Antifolates show promise against lung cancer subtype http://t.co/JYHEur01 #Healthnews
Patients with KRAS mutant NSCLC should respond well to antifolates
news-medical.net — “Patients with non-small cell lung cancer who have mutations in the KRAS gene should respond well to the antifolate class of drugs, according to results of a recent study conducted by Quintiles comparing human lung cancer cell lines and patients.” View full resource at news-medical.net
Most Recently Shared on November 14, 2011 at 10:26 am By:
Patients with KRAS mutant NSCLC should respond well to antifolates: Patients with non-small cell lung cancer who... http://t.co/1pDwlwFr
Study assesses link between antifolate medications, KRAS mutations and amplification
news-medical.net — “Testing patients with non-small cell lung cancer for both mutations and amplifications of the KRAS gene prior to therapy may help to predict response to treatment with antifolates, according to the updated results of a preclinical study presented at the AACR Annual Meeting 2012, held here March 31 - April 4.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:29 am By:
Lung Cancer News: Study assesses link between antifolate medications, KRAS mutations and amplification: Testing ... http://t.co/pTIigUcV
PCFT helps in effectively targeting cytotoxic antifolates to tumors: Study
news-medical.net — “Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit today presented a poster at the American Association for Cancer Research's 101st Annual Meeting 2010 that details their novel study of molecules that use a tumor's acidic microenvironment to help them tailor chemotherapeutic agents to kill the tumor.” View full resource at news-medical.net
Most Recently Shared on April 23, 2010 at 8:38 am By:
PCFT helps in effectively targeting cytotoxic antifolates to tumors: Study: Scientists at the Barbara Ann Karmanos... http://bit.ly/aGoGLb
Acino confirms the potential of iclaprim as a new antibiotic - Drugs.com MedNews
drugs.com — “Acino confirms the potential of iclaprim as a new antibiotic Basle, December 20, 2010, 07.00 hrs In November, 2010, representatives of Acino met with the US FDA” View full resource at drugs.com
Most Recently Shared on December 23, 2010 at 4:03 pm By:
Drugs and Devices OW OW Health
Acino confirms the potential of iclaprim as a new antibiotic: Acino confirms the potential of iclaprim as ... http://bit.ly/g2wi0w #drug
Family Medicine Article |
mdlinx.com — “Efficacy and safety of CH-1504, a metabolically stable antifolate, in patients with active rheumatoid arthritis: Results of a phase II multicenter randomized study” View full resource at mdlinx.com
Most Recently Shared on July 11, 2011 at 6:04 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy and safety of CH-1504, a metabolically stable antifolate, in patients with active rheumato... http://bit.ly/onZSPV #FamPractice
Rheumatology Article |
mdlinx.com — “Efficacy and safety of CH-1504, a metabolically stable antifolate, in patients with active rheumatoid arthritis: Results of a phase II multicenter randomized study” View full resource at mdlinx.com
Most Recently Shared on July 11, 2011 at 8:13 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy and safety of CH-1504, a metabolically stable antifolate, in patients with active rheumat... http://bit.ly/nIK6zk #Rheumatology
Medical News: ASCO: Antibody Shows Promise in Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Women with relapsed, platinum-sensitive ovarian cancer had a 70% overall response rate to treatment with a taxane plus an antifolate receptor antibody, data from a small clinical trial show” View full resource at medpagetoday.com
Most Recently Shared on June 10, 2010 at 3:06 pm By:
ASCO: Antibody Shows Promise in Ovarian Cancer http://bit.ly/9lsWH9
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Lung Cancer OW
Organizing lung cancer resources shared by health experts, advocates, and organizations into WisdomCards.
-
VirtualMedicalCentre
Your best resource for healthcare information
-
Lung Cancer OW
Organizing lung cancer resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
